Filing Details
- Accession Number:
- 0001553878-18-000026
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-03-16 17:05:38
- Reporting Period:
- 2018-03-14
- Accepted Time:
- 2018-03-16 17:05:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1178670 | Alnylam Pharmaceuticals Inc. | ALNY | Pharmaceutical Preparations (2834) | 770602661 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1291963 | E Barry Greene | 300 Third Street Cambridge MA 02142 | President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-03-14 | 2,884 | $140.43 | 97,544 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-03-14 | 7,250 | $141.74 | 90,294 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-03-14 | 9,217 | $142.68 | 81,077 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-03-14 | 8,644 | $143.58 | 72,433 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-03-14 | 9,165 | $144.67 | 63,268 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-03-14 | 1,300 | $145.41 | 61,968 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 2,810 | Indirect | by Managed Account |
Footnotes
- The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 11, 2018.
- Sale prices ranged from $140.00 to $140.95
- Sale prices ranged from $141.12 to $142.10
- Sale prices ranged from $142.12 to $143.11
- Sale prices ranged from $143.12 to $144.11
- Sale prices ranged from $144.14 to $145.13
- Sale prices ranged from $145.16 to $145.79
- The reporting person owns 2,827 shares of ALNY common stock under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program.
Billionaire Hedge Funds
